Nomura’s June 2025 analysis shows Indian pharma majors like Sun Pharma, Dr. Reddy’s, Cipla, Lupin, and Zydus posting strong specialty…
Elara Capital observes that Aurobindo Pharma has 14 biosimilars in the pipeline. The company has also filed 3 biosimilars for…
Sun Pharma slides 6% after weak Q1 FY26 results, but Motilal Oswal still recommends Buy—discover the three reasons to consider…
Dr Gaurav Kharya of Indraprastha Apollo Hospitals explains how stem cell therapies could potentially cure severe Type 1 diabetes. Explore…
Once the regulator’s guidance is accepted by the European Commission, the authorisation is valid in all 27 EU member countries…
AbbVie has entered into a $700 million licensing agreement with IGI Therapeutics to co-develop ISB 2001, a promising trispecific T-cell…
Nectar Lifesciences’ API and formulation business generated 98.33 percent of the company’s total revenue/ income in the fiscal year 2025.…
Worries about further hiccups in the potential trade deal and consequent higher tariffs between India and the United States are…
US pharma giant Eli Lilly has secured Indian regulatory approval to market Mounjaro pen, its widely used diabetes and weight-loss…
Cipla aims for FY26 growth via inorganic expansion and new product launches, especially 2-3 peptide assets. Its FY25 report highlights…
Glenmark said that the FDA has issued a Form 483 upon the conclusion of its inspection at the manufacturing facility.…
The presence of multinational pharma companies (MNCs) in India’s drug market continues to shrink, reaching 14.5% in May 2025 from…
What do these Warren Buffetts of India like Mukul Agarwal, Vijay Kedia, Ashish Kacholia and Vanaja Iyer have in common,…
Bharat Biotech to launch Hillchol, its oral cholera vaccine, amid a global shortage. With Phase III trials completed and 200M…
IHH’s NTK arm raises damages claim to Rs 11,800 crore against Daiichi Sankyo, alleging obstruction in Fortis Healthcare acquisition. Based…
Govt invites fresh applications under the PLI scheme to boost bulk drug production. Focus on 11 key APIs, KSMs, and…
Dinesh Madhavan, President – Group Oncology & International at Apollo Hospitals, emphasized that India’s healthcare system needs preventive vaccination; enforcement…
Investors are closely monitoring the performance of Indian pharma companies in the March 2025 quarter and their ability to grow…